Breast carcinoma and skin resistance

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.

NPJ precision oncology·2021

Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.

Clinical pharmacology and therapeutics·2016

Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2002

Upper abdominal obesity, insulin resistance and breast cancer risk.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2002

Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Modelling organic matter dynamics in New Zealand soils.

Environment international·2001

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.

Clinical and translational medicine·2026

CLIC3 promotes lung cancer cell proliferation by regulating intracellular chloride and ROS levels.

Gene·2026

Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.

Ageing research reviews·2026

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Oncogene·2026

Research advances in the recurrence patterns of glioblastoma.

Biochimica et biophysica acta. Reviews on cancer·2026

Related Experiment Videos

Breast carcinoma and skin resistance

Related Concept Videos

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.

Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.

Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention.

Upper abdominal obesity, insulin resistance and breast cancer risk.

Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications.

Modelling organic matter dynamics in New Zealand soils.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer.

ETS1-EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling.

CLIC3 promotes lung cancer cell proliferation by regulating intracellular chloride and ROS levels.

Aging's Competing Paradigms: Another Decade of Investigation into Damage-Driven versus Programmed Theories.

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Research advances in the recurrence patterns of glioblastoma.

Related Experiment Videos

Breast carcinoma and skin resistance

Related Concept Videos

Related Articles